Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2024-02-14
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Intervention for Speech Anxiety
NCT06086756
Enhancing Generalization of Virtual Reality Exposure for Public Speaking Anxiety
NCT07323498
ACT and Virtual Reality for Public Speaking Fear
NCT05573620
Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software
NCT03001154
Virtual Reality Exposure Therapy for Public Speaking Anxiety
NCT03885414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
One session therapy
One session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand
Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety
A 3-hour one session exposure therapy for public speaking anxiety
One session therapy - divided into 3
Three session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand
Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety
A 3-hour one session exposure therapy for public speaking anxiety
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety
A 3-hour one session exposure therapy for public speaking anxiety
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* experiencing a significant level of public speaking anxiety (60+ on PSAS);
* able to use a computer and have access to the internet for the duration of the study;
* able to understand, write and speak in Lithuanian;
* available to participate in one or three in-person intervention sessions and can devote the time to participate in a 4-week online program following the intervention sessions.
Exclusion Criteria
* other significant medical conditions that would prevent them from participating in the program;
* high levels of depression (Patient Health Questionnaire-9 rating of 15 and above and mentions of suicidal ideation) or other significant psychiatric conditions that would interfere with participation in the program;
* a tendency to have extreme seasickness reactions or a history of adverse physical reactions to virtual reality experiences or difficulty with or lack of stereoscopic vision;
* current involvement in other psychological interventions such as psychological counseling or psychotherapy;
* use of psychoactive drugs, unless stable for three months;
* current participation in other programs aimed at reducing public speaking anxiety.
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Linkoeping University
OTHER_GOV
Stockholm University
OTHER
Thomas More University of Applied Sciences
OTHER
Vilnius University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonas Eimontas, PhD
Role: STUDY_CHAIR
Vilnius University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vilnius University
Vilnius, , Lithuania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jonas Eimontas, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VRanx_001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.